TRIAD Trademark

Trademark Overview


On Tuesday, March 26, 1985, a trademark application was filed for TRIAD with the United States Patent and Trademark Office. The USPTO has given the TRIAD trademark a serial number of 73528922. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, December 16, 1985. This trademark is owned by UAD LABORATORIES, INC.. The TRIAD trademark is filed in the Pharmaceutical Products category with the following description:

PRESCRIPTION DRUG PRODUCT CONTAINING IN EACH CAPSULE 50 MG. BUTALBITAL, 325 MG. ACETAMINOPHEN, AND 40 MG. CAFFEINE

General Information


Serial Number73528922
Word MarkTRIAD
Filing DateTuesday, March 26, 1985
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, December 16, 1985
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPRESCRIPTION DRUG PRODUCT CONTAINING IN EACH CAPSULE 50 MG. BUTALBITAL, 325 MG. ACETAMINOPHEN, AND 40 MG. CAFFEINE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code8 - Abandoned
Class Status DateWednesday, August 4, 1999
Primary Code005
First Use Anywhere DateThursday, October 11, 1984
First Use In Commerce DateThursday, October 11, 1984

Trademark Owner History


Party NameUAD LABORATORIES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJACKSON, MS 39209

Trademark Events


Event DateEvent Description
Monday, December 16, 1985ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, May 20, 1985NON-FINAL ACTION MAILED
Thursday, May 16, 1985ASSIGNED TO EXAMINER